Ser334
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser334  -  C5aR (human)

Site Information
sVVREsKsFTRsTVD   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 448819

In vivo Characterization
Methods used to characterize site in vivo:
[32P] bio-synthetic labeling ( 5 , 6 ) , mass spectrometry ( 1 , 2 ) , mutation of modification site ( 3 , 4 , 5 , 6 ) , phospho-antibody ( 3 ) , phosphopeptide mapping ( 6 ) , western blotting ( 4 , 5 )
Disease tissue studied:
lung cancer ( 1 , 2 ) , non-small cell lung cancer ( 1 , 2 )
Relevant cell line - cell type - tissue:
COS (fibroblast) ( 5 , 6 ) , HL60 (myeloid) ( 5 , 6 ) , lung ( 1 , 2 ) , RBL-2H3 (basophil) ( 3 ) , RIN (epithelial) ( 4 ) , U-937 (myeloid) ( 3 )

Upstream Regulation
Putative in vivo kinases:
PKCB (human) ( 3 ) , PKCB iso2 (human) ( 3 )
Kinases, in vitro:
PKCA (human) ( 3 , 6 ) , PKCB (human) ( 3 ) , PKCB iso2 (human) ( 3 ) , PKCD (human) ( 3 ) , PKCG (human) ( 3 )
Treatments:
C5a ( 4 , 5 , 6 ) , phorbol_ester ( 6 )

Downstream Regulation
Effects of modification on C5aR:
molecular association, regulation ( 4 ) , receptor desensitization, altered ( 3 , 5 )
Induce interaction with:
ARRB1 (human) ( 4 ) , ARRB2 (human) ( 4 )

References 

1

Rikova K (2010) CST Curation Set: 9470; Year: 2010; Biosample/Treatment: tissue, /untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

2

Rikova K (2010) CST Curation Set: 9464; Year: 2010; Biosample/Treatment: tissue, lung/untreated; Disease: non-small cell lung cancer; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: p[STY])
Curated Info

3

Pollok-Kopp B, H├╝ttenrauch F, Rethorn S, Oppermann M (2007) Dynamics of protein kinase C-mediated phosphorylation of the complement C5a receptor on serine 334. J Biol Chem 282, 4345-53
17145764   Curated Info

4

Braun L, Christophe T, Boulay F (2003) Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway. J Biol Chem 278, 4277-85
12464600   Curated Info

5

Christophe T, et al. (2000) Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells. J Biol Chem 275, 1656-64
10636859   Curated Info

6

Giannini E, Brouchon L, Boulay F (1995) Identification of the major phosphorylation sites in human C5a anaphylatoxin receptor in vivo. J Biol Chem 270, 19166-72
7642584   Curated Info